• Markets
    • icon
  • Companies
AVE · ASX

Avecho Biotechnology Limited (ASX:AVE)

AU$0.003

 -5.0E-4 (-14.286%)
ASX:Live
30/11/2023 10:00:10 AM
Near Support (Realtime) HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AVE Overview

AVE Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About AVE

Website

Avecho Biotechnology Limited

Telephone

61.3.9002.5000

Address

Unit A8 2A Westall Road Clayton, Victoria (VIC) 3168

Description

Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates under the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.

AVE Price Chart

Key Stats

Market Cap

AU$12.68M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.02

Trade Value (12mth)

AU$3,020.00

1 week

-12.5%

1 month

-12.5%

YTD

-73.08%

1 year

-61.11%

All time high

0.424765

Key Fundamentals

EPS 3 yr Growth

-360.000%

EBITDA Margin

N/A

Operating Cashflow

-$2m

Free Cash Flow Return

-46.60%

ROIC

-65.50%

Interest Coverage

N/A

Quick Ratio

3.30

Other Data

Shares on Issue (Fully Dilluted)

1931m

HALO Sector

Healthcare

Next Company Report Date

28-Feb-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AVE Announcements

Latest Announcements

Date Announcements

31 October 23

September 2023 Quarterly Activities Report & Appendix 4C

×

September 2023 Quarterly Activities Report & Appendix 4C

31 May 21

Chair's Address and CEO Presentation

×

Chair's Address and CEO Presentation

31 May 21

2021 Annual General Meeting Results

×

2021 Annual General Meeting Results

31 May 21

Avecho Biotechnology Limited - Chair's Address and CEO Presentation (AVE-AU)

×

Avecho Biotechnology Limited - Chair's Address and CEO Presentation (AVE-AU)

31 May 21

Avecho Biotechnology Limited - 2021 Annual General Meeting Results (AVE-AU)

×

Avecho Biotechnology Limited - 2021 Annual General Meeting Results (AVE-AU)

31 January 23

December 2022 Quarterly Activities Report & Appendix 4C

×

December 2022 Quarterly Activities Report & Appendix 4C

31 January 23

Avecho Biotechnology Limited - December 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

×

Avecho Biotechnology Limited - December 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

31 January 22

December 2021 Quarterly Activities Report & Appendix 4C

×

December 2021 Quarterly Activities Report & Appendix 4C

31 January 22

Avecho Biotechnology Limited - December 2021 Quarterly Activities Report & Appendix 4C (AVE-AU)

×

Avecho Biotechnology Limited - December 2021 Quarterly Activities Report & Appendix 4C (AVE-AU)

31 August 23

Appendix 4D and Half-year Financial Report

×

Appendix 4D and Half-year Financial Report

30 May 22

Chair's Address and CEO Presentation

×

Chair's Address and CEO Presentation

30 May 22

2022 Annual General Meeting Results

×

2022 Annual General Meeting Results

30 May 22

Adoption of New Constitution

×

Adoption of New Constitution

30 April 21

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 April 21

Avecho Biotechnology Limited - Notice of Annual General Meeting/Proxy Form (AVE-AU)

×

Avecho Biotechnology Limited - Notice of Annual General Meeting/Proxy Form (AVE-AU)

29 May 23

USPTO allows new TPM manufacturing patent

×

USPTO allows new TPM manufacturing patent

29 March 22

Positive results from AVE's topical CBD pain study

×

Positive results from AVE's topical CBD pain study

29 July 22

June 2022 Quarterly Activities Report & Appendix 4C

×

June 2022 Quarterly Activities Report & Appendix 4C

29 July 22

Avecho Biotechnology Limited - June 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

×

Avecho Biotechnology Limited - June 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

29 August 22

Appendix 4D and Half-year Financial Report

×

Appendix 4D and Half-year Financial Report

29 April 22

March 2022 Quarterly Activities Report & Appendix 4C

×

March 2022 Quarterly Activities Report & Appendix 4C

29 April 22

Avecho Biotechnology Limited - March 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

×

Avecho Biotechnology Limited - March 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

28 October 22

September 2022 Quarterly Activities Report & Appendix 4C

×

September 2022 Quarterly Activities Report & Appendix 4C

28 October 22

Avecho Biotechnology Limited - September 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

×

Avecho Biotechnology Limited - September 2022 Quarterly Activities Report & Appendix 4C (AVE-AU)

28 November 23

Expiry of Quoted Options

×

Expiry of Quoted Options

28 June 23

Application for quotation of securities - AVE

×

Application for quotation of securities - AVE

AVE Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -440.0 -11.8 31.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -202.8 -19.9 30.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.1 -12.2 N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -43.8 73.7 -46.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,591 1,802 N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 1,591 1,802 N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -90.9 106.3 42.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 2 4 4 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -172.0 53.9 200.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -446.9 -99.8 70.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 547 200 30 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -4 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -324.3 -44.6 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -741.2 -519.4 N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 0 N/A Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -5 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -676.8 -34.3 32.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -880.7 -573.4 -271.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -5 -3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -410.0 -29.7 31.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -685.0 -430.5 -207.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 -3 -2 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 5 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -220.1 -131.1 48.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3.7 -4.2 -1.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 3 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 3 5 3 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 -3 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 3 5 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3 5 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.4 65.6 -42.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -78.5 -65.1 -70.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -99.3 -75.3 -96.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -88.3 -122.1 -83.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -70.1 -93.6 -65.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -37.9 -84.9 -46.6 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -481.1 -413.2 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 0.8 N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -64.3 -69.9 -50.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.5 6.9 3.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.3 6.6 3.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 69.6 67.9 51.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -235.8 -445.4 -223.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.6 1.0 1.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 16.9 10.7 1.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.2 0.5 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 28.7 9.5 16.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.2 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -778.7 -572.2 -262.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -89.3 -86.6 -88.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -78.5 -65.1 -70.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.2 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -99.3 -75.3 -96.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -99.3 -75.3 N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 21.6 34.2 325.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 585.8 369.3 302.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 607.4 403.5 627.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 18.4 20.1 89.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 589.0 383.4 538.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVE Shortsell

Frequently Asked Questions

The current share price of Avecho Biotechnology Limited (AVE:ASX) is AU$0.003.
The 52-week high share price for Avecho Biotechnology Limited (AVE:ASX) is AU$0.02.
The 52-week low share price for Avecho Biotechnology Limited (AVE:ASX)? is AU$0.00.
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
Avecho Biotechnology Limited (AVE:ASX) has a franking level of 0%.
Avecho Biotechnology Limited (AVE:ASX) is classified in the Healthcare.
The current P/E ratio for Avecho Biotechnology Limited (AVE:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.